Seed To Science

Seed To Science We want to build a community for healthy discussions and debates.

Here at Seed to Science, we want to use Facebook to expand our network and release regular content about cannabis and the development of products, treatments and regulations.

13/01/2020
https://prohibitionpartners.com/2019/12/06/125/
11/12/2019

https://prohibitionpartners.com/2019/12/06/125/

Prohibition Partners has examined the reasons behind the global cannabis market slump while Lyphe Group has signed an agreement with Avicanna to import medical cannabis into the UK, discover more in issue 125 of International Cannabis Weekly.

https://healthcarenewsnow.com/global-medical-ma*****na-market-2/
11/10/2019

https://healthcarenewsnow.com/global-medical-ma*****na-market-2/

New York City, NY: October 9, 2019 – Published via (Wired Release) – Global Medical Ma*****na Market investigated the popular situation in the descriptions, arrangements, applications, and business chain structure. The medical ma*****na market report also focuses on the development trends as wel...

Dirección

Gran Via De Les Corts Catalanes
Barcelona
08013

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Seed To Science publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Contacto El Consultorio

Enviar un mensaje a Seed To Science:

Compartir

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

ABOUT US

Seed To Science Ltd is an African and European business partner for your Cannabis venture. With a vast network spanning over the US, Canada, Europe, Australia, New Zealand, Latin America and Africa, Seed to Science Ltd will assist in growing your business, investments, and venture value. Contact us to see how we can help you make the right choices in a fast moving Global Cannabis Industry. Our partners are start-up companies, private companies, license holders, pharmacies, public companies, research facilities, market analysts, Funds, Governments, and VCs.